Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of post-anesthesia cough after thyroidectomy
IRCT20211209053338N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine in thyroid disease (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Cough. Started Jan 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
thyroid disease
Beyond the preview
Go deeper on IRCT20211209053338N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211209053338N1.